Cartalax is a synthetic three-amino-acid peptide (Ala-Glu-Asp, also called AED or T-31) from the same Russian research group as Epitalon. It is marketed as a bioregulator for cartilage and joints, but it is not approved as a drug in the US, and we found no human studies.
Also known as: Ala-Glu-Asp, AED peptide, T-31.
Cartalax powder vials are usually labeled 20 mg.
Water and syringe-unit charts by vial size: 20 mg
Here is the math for a 20 mg vial mixed with 2 mL of bacteriostatic water, drawing 1 mg with a U-100 insulin syringe (1 mL = 100 units).
20 mg ÷ 2 mL = 10 mg/mL1 mg ÷ 10 mg/mL = 0.1 mL0.1 mL × 100 = 10 units| Amount | Volume | U-100 syringe |
|---|---|---|
| 500 mcg | 0.05 mL | 5 units |
| 1 mg | 0.1 mL | 10 units |
| 2 mg | 0.2 mL | 20 units |
Adding more water doesn't change how much cartalax is in the vial. It only spreads it over more liquid, so each draw is bigger and easier to read.
| Water added | Concentration | Volume | U-100 syringe |
|---|---|---|---|
| 1 mL | 20 mg/mL | 0.05 mL | 5 units |
| 2 mL | 10 mg/mL | 0.1 mL | 10 units |
| 3 mL | 6.67 mg/mL | 0.15 mL | 15 units |
| 5 mL | 4 mg/mL | 0.25 mL | 25 units |
For any other vial size or amount, the free peptide reconstitution calculator works backwards from the amount you want and suggests a water volume that lands on a clean syringe mark.
Published work on Ala-Glu-Asp is in cell cultures. It changed the activity of aging-related genes in human stem cells (Ashapkin 2020), lowered an enzyme that breaks down tissue (MMP-9) and raised a marker of cell division in aging skin cells (Lin'kova 2016), and slowed markers of aging in kidney cells (Khavinson 2014).
We could not find any study of cartalax in cartilage or joints, in animals or in people.
We could not find a published human half-life for this compound. Figures quoted online usually come from animal or cell studies, so we do not list one here.
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator